AI Articles and Analysis about Business intelligence and analytics

Although one might assume healthcare companies are investing the most amount of money into AI for R&D efforts, such as clinical trials, drug discovery, and surgical robotics, the top healthcare companies don't seem to be publicizing their efforts if they are.

Various use cases and applications for AI and machine learning in the healthcare industry are proposed more frequently now than ever. Healthcare leaders may find it difficult to keep up with where AI is being applied in their sector.

Machine learning has far-ranging applications in the finance space broadly from document digitization to document search, chatbots to fraud detection. The insurance space in particular, however, stands to benefit from AI and machine learning applications in a few unique ways. They could help insurance firms with a challenge that’s at the forefront of the insurance world: attracting and meeting the needs of millennial customers.

We've spoken to many leaders in healthcare and pharma over the last half a decade, and when it comes to AI, the most pressing challenge that healthcare and pharma leaders report is that they're unsure of how to streamline and structure their data in a way that lets them build machine learning models. Healthcare companies are stuck in the data consolidation phase of their potential AI initiatives while vendor after vendor is trying to sell them on a new application that the company might not even be close to ready for.

The finance sector has proven itself an early adopter of AI in comparison to other industries. As such, the applications of artificial intelligence and machine learning in finance are myriad. Traders, wealth managers, insurers, and bankers are likely well aware of this in some form.

Natural language processing (NLP) seems to see less use in pharma than AI approaches such as machine vision and predictive analytics, but nevertheless there are a few applications for NLP in pharma. The industry deals mostly with structured data, but in some business areas, unstructured data is the norm. In this article, we discuss how natural language processing can help pharmaceutical companies make sense of their unstructured data and use it to make decisions.

Business leaders in pharmaceuticals may be concerned with how machine vision will affect their operations in the clinical and scientific departments more than those of packaging and administration. However, prioritizing these types of operations may not provide the ROI as it’s hyped up to be. Instead, there are many possibilities for machine vision in pharmaceuticals related to packaging, shipping, and data entry.

AI applications for the insurance industry have certainly garnered a lot of press lately. We’ve previously covered such applications in the American and European insurance spaces. Countries in Asia such as China and Japan have large insurance industries and seem to have established national AI strategies.